Moreover, recent studies demonstrate existence of a linear signaling pathway between Her2 and HSF1 in Her2-positive breast cancer, both in vitro (13, 46, 47) and in vivo (4, 47). The gene discussed is HSF1; the disease is breast carcinoma.